Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis.

This meta-analysis provides evidence of a significant positive association between DM and risk of CIPN. Furthermore, a more detailed evaluation is warranted for cancer patients with diabetes when they are treated with antineoplastic drugs that have the potential to cause peripheral neuropathy.